Navigation Links
HIV Drug Combo can Boost Immune Marker in Long-term Patients: Study

Patients who successfully respond to drugs that combat the AIDS virus can see a key marker of immune health rebound to a level enjoyed by people without HIV, a study published online Wednesday by The Lancet says.

The paper sheds light on poorly understood conditions as to why some people on antiretroviral drugs can boost and maintain their CD4 immune cells, others see a slower increase in these key defenders while other individuals fail, sometimes tragically so.

Investigators led by Amanda Mocroft of London's Royal Free Centre for HIV Medicine looked at 1,835 people with the human immunodeficiency virus (HIV) before and after they were put on antiretrovirals.

On average, these individuals had a CD4 count of 204 cells per microlitre of blood at the start of the study.

In the first year of taking antiretrovirals, there was a big spurt in the CD4 count, of around 100 cells per microlitre on average.

HIV levels were also suppressed, to below 50 copies of the virus per microlitre, which is considered a key goal in antiretroviral treatment.

Over the next few years, lower -- but still significant -- improvements in the CD4 count continued.

In fact, after three years, patients who had started therapy with a CD4 count of more than 350 cells per microlitre had a CD4 count "approaching the level seen in HIV-negative individuals," Mocroft says.

On average, the boost was around 50 cells per microlitre annually, and this continued even up to the fifth year of treatment, which by the standards of HIV therapy is a long time indeed.

Most rewarding of all was that this enduring improvement was seen among patients who had had low CD4 cells (of less than 200 cells per microlitre) before they began therapy.

Those who began with more than 500 CD4 cells per microlitre saw the least relative improvement.

The upturn in CD4 cells only occu
'"/>




Page: 1 2

Related medicine news :

1. Drug Combo Works Better for children with ADHD, Tics
2. Scanning Combo Helps Detect Lung Cancer
3. Relief From Asthma With New Combo Therapy
4. Calcium-Vitamin D Combo For Reduced Fracture Risk
5. Drug Combo Improves Performance Of Multiple Sclerosis Drug
6. Alcohol-illusion: Alcohol and Energy Drinks Combo, Maintains Sobriety?
7. HER-2 Positive Breast Cancer Patients May Benefit With a Combo Drug Strategy
8. The Combo Treatment Is Effective to Treat Type 1 Diabetes in Mice
9. Doomed Duo: Obesity and Type 2 Diabetes Combo, Can Nip Life in the Bud
10. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
11. Fuzeon and MK-0518 Combo Holds Promise For HIV
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: HIV Drug Combo can Boost Immune Marker Long term Patients Study

(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... 2015 On March 2, 2015, NBC ... on the Rise, Plastic Surgeons Say,” that comments on ... for Aesthetic Plastic Surgery and the American ... a year-over-year doubling of surgical butt augmentations performed in ... the article, this increase can be attributed to the ...
(Date:3/5/2015)... HMP Communications Holdings , ... education, announced today its acquisition of the ... medical conference designed for health care providers dedicated ... amputation due to vascular disorders. The 5-year-old ... publications and CME activities across therapeutic fields such ...
(Date:3/5/2015)... Venice, FL (PRWEB) March 05, 2015 ... their 15th annual listing of “Pros to Know” in ... announce that two members of MEBC’s leadership team were ... Rhodes were nominated and received this award due to ... use of innovative methods for meeting and resolving client ...
(Date:3/5/2015)... 2015 Leading nutritional supplement provider ... Sports Festival and Arnold Fitness EXPO in ... will host a display booth featuring free samples of ... its highly-popular, class-leading fat burner Synedrex. The company will ... that utilize its top-of-the-line supplements and miniature action figures ...
Breaking Medicine News(10 mins):Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 2Health News:HMP Holdings Acquires The Amputation Prevention Symposium (AMP) 3Health News:MEBC Leaders Awarded Supply Demand Chain Executive Pros to Know Title For 2015 2Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2
... test by using EEG can predict whether a person ... by Leslie S. Prichep of the New York University School ... 44 patients and followed these people for a decade. The ... would develop dementia. ,Dementia is a brain disorder that causes ...
... research from the National Institute of Diabetes and Digestive and ... shown stabalisation of annual increases from 5 to 10 ... there is still a dramatic racial disparity. , ... than 1 percent since 1999, compared to an average 5 ...
... cancer vaccine trial against Melanoma which is a type ... vaccine developed by Antigenics.// The vaccine trial of Oncophage ... the required statistically significance results compared to prolongation in ... any better results compared to other cancer treatments. ...
... a near-pandemic condition that threatens millions with loss of ... atherosclerotic plaque in the arteries outside your heart.// Stem ... blood vessels and grow new ones thus restoring blood ... Ltd, a private, multinational company focuses on using stem ...
... inflammation according to scientists. Inflammation has a role to ... cardiovascular disease, diabetes, obesity, Alzheimer’s besides infections//. , ... said: “Practically every common disease involves an inflammation component,” ... Research (SFBR) in San Antonio., ,“So the discovery ...
... following ace cricketer Sachin Tendulkar's and several other players complaining ... the sports arena//. ,Tennis elbow, or lateral epicondylitis ... where the outer part of the elbow becomes painful and ... or a direct bang. The problem occurs following overuse of ...
Cached Medicine News:Health News:US Kidney Failure Rates show Stabilization After 20-Year Climb 2Health News:Tennis elbow not new among cricketers, say experts 2
(Date:3/5/2015)... EDISON, N.J. , March 5, 2015  ContraVir ... company focused on the development and commercialization of targeted ... the 27 th Annual ROTH Conference, to be ... CA. James Sapirstein , ... Company,s business during his live presentation and will be ...
(Date:3/5/2015)... March 5, 2015 According to ... by Product (Systems and Disposables), by Type (Invasive, Minimally ... Home and Ambulatory Sites) - Analysis & Global Forecast ... is expected to reach $1,107.4 Million by 2019 from ... at a CAGR of 4.5% during the forecast period. ...
(Date:3/5/2015)... Denmark , March 5, 2015 ... that applies its innovative TransCon technology to address ... present two posters at the ENDO 2015 conference ... The posters will be presented on Thursday, March ... is being held from 1:00pm-3:00pm PST, and are ...
Breaking Medicine Technology:ContraVir to Present at 27th Annual ROTH Conference 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4Ascendis Pharma to Present at ENDO 2015 2
... Worldwide, MENLO PARK, Calif., Nov. 15 ... global Phase III clinical program to,evaluate the efficacy ... program, which includes the COGENT-1 and COGENT-2 trials, ... in the United States, Canada,Europe and South America. ...
... Calif., Nov. 15 BiPar,Sciences, Inc., a privately ... it has initiated a Phase 2 study of ... breast,cancer that do not express the estrogen, progesterone ... Phase 2 trial in this indication-which,represents a major ...
Cached Medicine Technology:Cogentus to Launch Phase III Program of Novel Combination Product Designed to Reduce Bleeding Side Effect of Antiplatelet Therapy 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 2BiPar Begins Phase 2 Study of Lead PARP Inhibitor in Triple-Negative Breast Cancer Based on Overexpression Biomarker Data 3
... inhalers., ,ACE ensures prompt, effective delivery ... versatile design allows it to be used ... an endotracheal airway or resuscitation bag and ... be used in conjunction with an incentive ...
With ten colors available, Spectrums line of Color-Coded Fiberoptic Light Cables makes it easy to track by department....
... four models in proven halogen technology and ... find the right solution for every application: ... combination of two or three mobile lamps ... an on/off switch on the lamp housing, ...
Advanced Lighting System with Multi-Lamp Design providing Surgeon Focus Control and Extended, Variable Depth of Field over greater working distances. High Intensity, Cool Beam Temperature...
Medicine Products: